February 27, 2023 | Press Releases BICO introduces new life sciences manufacturing platform integrating ABB Robotics technology
September 13, 2022 | Press Releases SCIENION and Cellenion launch the proteoCHIP LF 48, for label-free single-cell proteomics sample preparation on the cellenONE® platform
July 28, 2022 | Press Releases SCIENION announces expansion in the UK with the opening of new R&D and manufacturing facilities
April 13, 2022 | Press Releases SCIENION celebrates the laying of the foundation stone for new headquarters in Berlin Adlershof
March 2, 2022 | Press Releases The study demonstrated the success of an optofluidic-based Point-of-Care (PoC) diagnostic system for the analysis of protein-protein interactions. Today SCIENION, a BICO company and leading […] SCIENION Announces Study Results for PoC-BoSens, an Optofluidic-based Infectious Disease Diagnostic Platform
January 19, 2022 | Press Releases The breakthrough diagnostics platform uses a multiplexed lateral flow assay that detects 10 bladder cancer biomarkers from a urine sample in either laboratory or point-of-care […] SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform
November 3, 2021 | Press Releases Available today, the proteoCHIP 12*16 facilitates automated, miniaturized solutions for single cell proteomics applications Today, SCIENION & Cellenion, BICO companies, announced the release of the […] SCIENION & Cellenion Announce the Launch of the proteoCHIP 12*16 for Single Cell Proteomics Sample Preparation on the cellenONE® Platform
October 27, 2021 | Press Releases The new platform broadens Cellenion’s single cell dispensing solutions portfolio by enabling the isolation and handling of cellular aggregates from 80 µm to 600 µm […] SCIENION & Cellenion Launch spheroONE®, a Large-Particle Sorter and Dispenser to Advance Drug Testing on Complex In-Vitro 3D Models
September 28, 2021 | Press Releases The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance […] SCIENION and Pictor Limited Partner to Commercialize High-Throughput SARS-CoV-2 Antibody Testing System to Support Ongoing Fight Against Pandemic
August 26, 2021 | Press Releases The two companies will work with the Environmental Molecular Science Laboratory, a U.S. Department of Energy user facility located at PNNL, and will leverage Cellenion’s [...] SCIENION and Cellenion Exclusively License PNNL-Developed Tech and Partner to Accelerate Sample Processing for Mass-Spectrometry